Skip to main content
SpringerLink
Log in

Why is Erythropoietin Made in the Kidney?

The kidney functions as a ’critmeter’ to regulate the hematocrit

  • Conference paper
Book cover Hypoxia

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 543))

Abstract

The normal hematocrit is not a random number,but one that maximizes oxygen delivery. While the feedback loop wherein tissue oxygen pressure determines the production of erythropoietin,which further drives the production of red blood cells in the bone marrow,explains how the hematocrit is generated, it does not speak to how the hematocrit is regulated. The regulation of the hematocrit requires the coordination of the plasma volume and the red cell mass. By controlling red cell mass via erythropoietin and plasma volume through excretion of salt and water,the kidney is able to generate the hematocrit. It is hypothesized that the kidney functions as a critmeter by sensing the relative volumes of each component of the blood through the common signal of tissue oxygen tension. The kidney’s unique ability to sense ECF volume through tissue oxygen signal allows it to coordinate these two volumes to produce the normal hematocrit. Hence,it may be the kidneys ability to report a measure of ECF volume as a tissue oxygen signal and thus to regulate the hematocrit that establishes it as the logical site of erythropoietin production. The critmeter is proposed to be a functional unit located at the tip of the cortical labyrinth at the juxta-medullary region of the kidney where erythropoietin is made physiologically. Renal vasculature and nephron segment heterogeneity in sodium reabsorption likely provides the anatomical construct to generate the marginal tissue oxygen pressure required to trigger the production of erythropoietin. The balance of oxygen consumption for sodium reabsorption and oxygen delivery is reflected by the tissue oxygen pressure. This balance hence determines RBC mass adjusted to plasma volume. Factors that affect blood supply and sodium reabsorption in a discordant manner may modulate the critmeter, e.g. angiotensin II. The objective of this work is to describe the hypothesis of the kidney’s function as a critmeter, including the anatomical and physiological components,and the role of the renin-angiotensin system in modulating erythropoietin. Clinical examples of the dysregulation of the critmeter may be found in the anemia of renal failure and in sports anemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abu-Alfa,A. K.,D. Cruz,M. A. Perazella,R. L. Mahnensmith,D. Simon,and M. J. Bia. ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients. American Journal of Kidney Diseases. 35: 1076–1082,2000.

    Article  CAS  PubMed  Google Scholar 

  2. Aeberhard,J. M.,P. A. Schneider,M. B. Vallotton,A. Kurtz,and M. Leski. Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients. Transplantation. 50: 613–616,1990.

    Article  CAS  PubMed  Google Scholar 

  3. Albitar,S.,R. Genin,M. Fen-Chong,M.O. Serveaux,and B. Bourgeon. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. Nephrology Dialysis Transplantation. 13: 1206–1210,1998.

    Article  CAS  Google Scholar 

  4. Bachmann,S.,M. Le Hir,and K. U. Eckardt. Co-localization of erythropoietin mRNA and ecto-5’-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. Journal of Histochemistry & Cytochemistry. 41: 335–341,1993.

    Article  CAS  Google Scholar 

  5. Balaban,E. P. Sports anemia. Clinics in Sports Medicine. 11: 313–325,1992.

    CAS  PubMed  Google Scholar 

  6. Bankir,L,Bouby,N,and Trinh-Trang-Tan,MM. Organization of the medullary circulation: Functional implications,in Nephrology: Proceedings of the IXth International Congress of Nephrology. Robinson,RR. 84–106. 1984. New York,Springer-Verlag.

    Google Scholar 

  7. Bauer,C. and A. Kurtz. Oxygen sensing in the kidney and its relation to erythropoietin production. Annual Review of Physiology. 51: 845–856,1989.

    Article  CAS  PubMed  Google Scholar 

  8. Blumberg,A.,H. Keller,and H. R. Marti. Effect of altitude on erythropoiesis and oxygen affinity in anaemic patients on maintenance dialysis. European Journal of Clinical Investigation. 3: 93–97,1973.

    Article  CAS  PubMed  Google Scholar 

  9. Brezis,M. and S. Rosen. Hypoxia of the renal medulla--its implications for disease. New England Journal of Medicine. 332: 647–655,1995.

    Article  CAS  PubMed  Google Scholar 

  10. Cazzola,M. and Y. Beguin. New tools for clinical evaluation of erythron function in man. British Journal of Haematology. 80: 278–284,1992.

    Article  CAS  PubMed  Google Scholar 

  11. Ceresne,L,Shah,B,and Donnelly,S. The functional nature of erythropoietin deficiency in the anemia of chronic renal failure. 1999.

    Google Scholar 

  12. Chandra,M.,G. K. Clemons,and M. I. McVicar. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. Journal of Pediatrics. 113: 1015–1021,1988.

    Article  CAS  PubMed  Google Scholar 

  13. Cohen,J. J. Relationship between energy requirements for Na+ reabsorption and other renal functions. Kidney International. 29: 32–40,1986.

    Article  CAS  PubMed  Google Scholar 

  14. Conlon,P. J.,F. Albers,D. Butterly,and S. J. Schwab. ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. Nephrology Dialysis Transplantation. 9: 1358,1994.

    CAS  Google Scholar 

  15. Cruz,D. N.,M. A. Perazella,A. K. Abu-Alfa,and R. L. Mahnensmith. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance? American Journal of Kidney Diseases. 28: 535–540,1996.

    Article  CAS  PubMed  Google Scholar 

  16. Daghman,N. A.,G. E. Elder,G. A. Savage,P. C. Winter,A. P. Maxwell,and T. R. Lappin. Erythropoietin production: evidence for multiple oxygen sensing pathways. Annals of Hematology. 78: 275–278,1999.

    Article  CAS  PubMed  Google Scholar 

  17. Donnelly,S. and B. R. Shah. Erythropoietin deficiency in hyporeninemia. American Journal of Kidney Diseases . 33: 947–953,1999.

    Article  CAS  PubMed  Google Scholar 

  18. Donnelly,S. M. and J. A. Miller. Losartan may modulate erythropoietin production. Journal of the Renin-Angiotensin-Aldosterone System. 2: 255–260,2001.

    Article  CAS  PubMed  Google Scholar 

  19. Dressendorfer,R. H.,C. E. Wade,and E. A. Amsterdam. Development of pseudoanemia in marathon runners during a 20-day road race. JAMA. 246: 1215–1218,1981.

    Article  CAS  PubMed  Google Scholar 

  20. Dworkin,L. and B. Brenner.The renal circulations. In Brenner,E.,ed.,The Kidney. Philadelphia,W.B.Saunders Co. 1996,211–246.

    Google Scholar 

  21. Eckardt,K. U.,U. Boutellier,A. Kurtz,M. Schopen,E. A. Koller,and C. Bauer. Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. Journal of Applied Physiology. 66: 1785–1788,1989.

    CAS  PubMed  Google Scholar 

  22. Eckardt,K. U.,A. Kurtz,and C. Bauer. Regulation of erythropoietin production is related to proximal tubular function. American Journal of Physiology. 256: t–7,1989.

    Google Scholar 

  23. Ehmke,H.,A. Just,K. U. Eckardt,P. B. Persson,C. Bauer,and H. R. Kirchheim. Modulation of erythropoietin formation by changes in blood volume in conscious dogs. Journal of Physiology. 488: 181–191,1995.

    CAS  PubMed Central  PubMed  Google Scholar 

  24. Erslev,A. J. Erythropoietin. New England Journal of Medicine. 324: 1339–1344,1991.

    Article  CAS  PubMed  Google Scholar 

  25. Erslev,A. J.,J. Caro,and A. Besarab. Why the kidney? Nephron. 41: 213–216,1985.

    Article  CAS  PubMed  Google Scholar 

  26. Eschbach,J. W. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney International. 35: 134–148,1989.

    Article  CAS  PubMed  Google Scholar 

  27. Fan,F. C,R. Y. Chen,G. B. Schuessler,and S. Chien. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. American Journal of Physiology 238: H545–22,1980

    Google Scholar 

  28. Ge,R. L.,S. Witkowski,Y. Zhang,C. Alfrey,M. Sivieri,T. Karlsen,G. K. Resaland,M. Harber,J. Stray-Gundersen,and B. D. Levine. Determinants of erythropoietin release in response to short-term hypobaric hypoxia. Journal of Applied Physiology. 92: 2361–2367,2002.

    CAS  PubMed  Google Scholar 

  29. Goldberg,M. A.,S. P. Dunning,and H. F. Bunn. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science. 242: 1412–1415,1988.

    Article  CAS  PubMed  Google Scholar 

  30. Griffing,G. T. and J. C. Melby. Enalapril (MK-421) and the white cell count and haematocrit. Lancet. 1: 1361,1982.

    CAS  PubMed  Google Scholar 

  31. Gullans,S. and S. Hebert.Metabolic basis of ion transport. In Brenner,E.,ed.,The Kidney. Philadelphia,W.B.Saunders Co. 1996,211–246.

    Google Scholar 

  32. Gurney,C,L. Jacobson,and E. Goldwasser. The physiologic and clinical significance of erythropoietin. Annals of Internal Medicine 49: 363–370,1958.

    Article  CAS  PubMed  Google Scholar 

  33. Hess,E.,H. Sperschneider,and G. Stein. Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients? Nephrology Dialysis Transplantation. 11: 749–751,1996.

    Article  CAS  Google Scholar 

  34. Hirakata,H.,K. Onoyama,K. Hori,and M. Fujishima. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients. Clinical Nephrology. 26: 27–32,1986.

    CAS  PubMed  Google Scholar 

  35. Hirakata,H.,K. Onoyama,K. Iseki,H. Kumagai,S. Fujimi,and T. Omae. Worsening of anemia induced by long-term use of captopril in hemodialysis patients. American Journal ofNephrology. 4: 355–360,1984.

    Article  CAS  Google Scholar 

  36. Hsu,C. Y,D. W. Bates,G. J. Kuperman,and G. C. Curhan. Relationship between hematocrit and renal function in men and women. Kidney International. 59: 725–731,2001.

    Article  CAS  PubMed  Google Scholar 

  37. Ichikawi,I. and R. C. Harris. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney International. 40: 583–596,1991.

    Article  CAS  PubMed  Google Scholar 

  38. Julian,B. A.,R. S. Gaston,C. V. Barker,G. Krystal,A. G. Diethelm,and J. J. Curtis. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney International. 46: 1397–1403,1994.

    Article  CAS  PubMed  Google Scholar 

  39. Kamper,A. L. and O. J. Nielsen. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scandinavian Journal of Clinical & Laboratory Investigation. 50: 611–618,1990.

    Article  CAS  Google Scholar 

  40. Koury,S. T.,M. J. Koury,M. C. Bondurant,J. Caro,and S. E. Graber. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit,renal erythropoietin mRNA,and serum erythropoietin concentration. Blood. 74: 645–651,1989.

    CAS  PubMed  Google Scholar 

  41. Kramer,K. and P. Deetjen.Oxygen consumption and sodium reabsorption in the mammalian kidney. In Dickens,N.,ed.,Oxygen in the Animal Organism. Pergamon,Oxford. 1993,411431.

    Google Scholar 

  42. Kurtz,A. and K. U. Eckardt. Erythropoietin production in chronic renal disease before and after transplantation. Contributions to Nephrology. 87: 15–25,1990.

    CAS  PubMed  Google Scholar 

  43. Lacombe,C,J. L. Da Silva,P. Bruneval,J. G. Fournier,F. Wendling,N. Casadevall,J. P. Camilleri,J. Bariety,B. Varet,and P. Tambourin. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. Journal of Clinical Investigation. 81: 620–623,1988.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Le Hir,M.,K. U. Eckardt,B. Kaissling,S. T. Koury,and A. Kurtz. Structure-function correlations in erythropoietin formation and oxygen sensing in the kidney. Klinische Wochenschrift. 69: 567–575,1991.

    Article  PubMed  Google Scholar 

  45. Lenga,I and Donnelly,S. Angiotensin II stimulates erythropoietin production in humans. Journal of the American Society of Nephrology 11,45 A. 2000.

    Google Scholar 

  46. Malik,T.,T. Youmbissi,R. Ghacha,M. Abdulrahman,A. Khursanny,and A. Karkar. Deep vein thrombosis in a renal transplant patient with erythrocytosis after stopping captopril. Dialysis & Transplantation Nov: 762,2001.

    Google Scholar 

  47. Martino,R.,A. Oliver,J. M. Ballarin,and A. F. Remacha. Postrenal transplant erythrocytosis: further evidence implicating erythropoietin production by the native kidneys. Annals of Hematology. 68: 201–203,1994.

    Article  CAS  PubMed  Google Scholar 

  48. Matsumura,M.,H. Nomura,I. Koni,and H. Mabuchi. Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients. Risks of Cardiac Disease in Dialysis Patients Study Group. Nephron. 77: 164–168,1997.

    Article  CAS  PubMed  Google Scholar 

  49. Maxwell,P. H.,M. K. Osmond,C. W. Pugh,A. Heryet,L. G. Nicholls,C. C. Tan,B. G. Doe,D. J. Ferguson,M. H. Johnson,and P. J. Ratcliffe. Identification of the renal erythropoietinproducing cells using transgenic mice. Kidney International. 44: 1149–1162,1993.

    Article  CAS  PubMed  Google Scholar 

  50. McGonigle,R. J.,J. D. Wallin,R. K. Shadduck,and J. W. Fisher. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney International. 25: 437–444,1984.

    Article  CAS  PubMed  Google Scholar 

  51. Nagashima,K.,J. Wu,S. A. Kavouras,and G. W. Mack. Increased renal tubular sodium reabsorption during exercise-induced hypervolemia in humans. Journal of Applied Physiology. 91: 1229–1236,2001.

    CAS  PubMed  Google Scholar 

  52. Nowicki,M.,F. Kokot,and A. Wiecek. Influence of the renin-angiotensin system stimulation on erythropoietin production in patients with various forms of arterial hypertension. Nephron. 65: 527–532,1993.

    Article  CAS  PubMed  Google Scholar 

  53. Oparil,S. and E. Haber. The renin-angiotensin system (first of two parts). New England Journal of Medicine. 291: 389–401,1974.

    Article  CAS  PubMed  Google Scholar 

  54. Piroso,E.,A. J. Erslev,K. K. Flaharty,and J. Caro. Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows. American Journal of Hematology. 36: 105–110,1991.

    Article  CAS  PubMed  Google Scholar 

  55. Radtke,H. W.,A. Claussner,P. M. Erbes,E. H. Scheuermann,W. Schoeppe,and K. M. Koch. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood. 54: 877–884,1979.

    CAS  PubMed  Google Scholar 

  56. Ratcliffe,P. J. Molecular biology of erythropoietin. Kidney International. 44: 887–904,1993.

    Article  CAS  PubMed  Google Scholar 

  57. Remacha,A. F.,J. Ordonez,M. J. Barcelo,F. Garcia-Die,B. Arza,and A. Estruch. Evaluation of erythropoietin in endurance runners. Haematologica. 79: 350–352,1994.

    CAS  PubMed  Google Scholar 

  58. Roberts,D. Erythropoietin Production as a Physiological Response to Exercise. 1996. Department of Medical Science,University of Calgary.

    Google Scholar 

  59. Roberts,D. and D. J. Smith. Erythropoietin concentration and arterial haemoglobin saturation with supramaximal exercise. Journal of Sports Sciences. 17: 485–493,1999.

    Article  CAS  PubMed  Google Scholar 

  60. Roberts,D.,D. J. Smith,S. Donnelly,and S. Simard. Plasma-volume contraction and exerciseinduced hypoxaemia modulate erythropoietin production in healthy humans. Clinical Science. 98: 39–45,2000.

    Article  CAS  PubMed  Google Scholar 

  61. Schultze,R. G.,F. Weisser,and N. S. Bricker. The influence of uremia on fractional sodium reabsorption by the proximal tubule of rats. Kidney International. 2: 59–65,1972.

    Article  CAS  PubMed  Google Scholar 

  62. Schurek,H. J.,U. Jost,H. Baumgartl,H. Bertram,and U. Heckmann. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. American Journal of Physiology. 259: t–5,1990.

    Google Scholar 

  63. Schuster,S. J.,J. H. Wilson,A. J. Erslev,and J. Caro. Physiologic regulation and tissue localization of renal erythropoietin messenger RNA. Blood. 70: 316–318,1987.

    CAS  PubMed  Google Scholar 

  64. Skott,O. and B. L. Jensen. Cellular and intrarenal control of renin secretion. Clinical Science. 84: 1–10,1993.

    CAS  PubMed  Google Scholar 

  65. Stenzel,K. H.,J. S. Cheigh,J. F. Sullivan,L. Tapia,R. R. Riggio,and A. L. Rubin. Clinical effects of bilateral nephrectomy. American Journal of Medicine. 58: 69–75,1975.

    Article  CAS  PubMed  Google Scholar 

  66. Tan,C. C,K. U. Eckardt,J. D. Firth,and P. J. Ratcliffe. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. American Journal of Physiology. 263: t–81,1992.

    Google Scholar 

  67. Vlahakos,D. V.,C. Balodimos,V. Papachristopoulos,P. Vassilakos,E. Hinari,and J. G. Vlachojannis. Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients. Clinical Nephrology. 43: 53–59,1995.

    CAS  PubMed  Google Scholar 

  68. Vlahakos,D. V.,V. J. Canzanello,M. P. Madaio,and N. E. Madias. Enalapril-associated anemia in renal transplant recipients treated for hypertension. American Journal of Kidney Diseases. 17: 199–205,1991.

    CAS  PubMed  Google Scholar 

  69. Walter,J. Does captopril decrease the effect of human recombinant erythropoietin in haemodialysis patients? Nephrology Dialysis Transplantation . 8: 1428,1993.

    CAS  Google Scholar 

  70. Weight,L. M.,D. Alexander,T. Elliot,and P. Jacobs. Erythropoietic adaptations to endurance training. European Journal of Applied Physiology & Occupational Physiology. 64: 444–448,1992.

    Article  CAS  Google Scholar 

  71. Weight,L. M.,B. L. Darge,and P. Jacobs. Athletes’ pseudoanaemia. European Journal of Applied Physiology & Occupational Physiology. 62: 358–362,1991.

    Article  CAS  Google Scholar 

  72. Weight,L. M,M. Klein,T. D. Noakes,and P. Jacobs. ’Sports anemia’--a real or apparent phenomenon in endurance-trained athletes? International Journal of Sports Medicine. 13: 344–347,1992.

    Article  CAS  PubMed  Google Scholar 

  73. Zhu,H. and H. F. Bunn. Oxygen sensing and signaling: impact on the regulation of physiologically important genes. Respiration Physiology. 115: 239–247,1999.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Authors
  1. Sandra Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Colorado Center for Altitude Medicine and Physiology, University of Colorado Health Sciences Center, Denver, Colorado, USA

    Robert C. Roach  & Peter H. Hackett (President) &  (President)

  2. University of California, San Diego, La Jolla, California, USA

    Peter D. Wagner

  3. International Society for Mountain Medicine, Ridgway, Colorado, USA

    Peter H. Hackett (President) (President)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic/Plenum Publishers,New York

About this paper

Cite this paper

Donnelly, S. (2003). Why is Erythropoietin Made in the Kidney?. In: Roach, R.C., Wagner, P.D., Hackett, P.H. (eds) Hypoxia. Advances in Experimental Medicine and Biology, vol 543. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8997-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8997-0_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4753-8

  • Online ISBN: 978-1-4419-8997-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation